Ann Luna
Nurse Practitioner · Livingston, TXNPI 1114331311
Payments from drug & device makers
Across 72 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$237
- Sunovion Pharmaceuticals Inc.$129
- Dexcom, Inc.$79
- Amgen$78
- Tactile Systems Technology Inc$68
- Otsuka America Pharmaceutical, Inc.$67
- plus $603 from 20 others
What the payments were for
- Food & beverage$1,24799%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 12 | $237 |
| Sunovion Pharmaceuticals Inc. | 10 | $129 |
| Dexcom, Inc. | 4 | $79 |
| Amgen | 5 | $78 |
| Tactile Systems Technology Inc | 5 | $68 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Medtronic | 1 | $61 |
| Lilly USA, LLC | 4 | $59 |
| Mylan Specialty L.p. | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Eisai Inc. | 2 | $43 |
| Johnson & Johnson | 3 | $41 |
| Pfizer | 2 | $37 |
| Merck | 2 | $30 |
| AbbVie | 1 | $29 |
| Astellas Pharma US Inc | 1 | $24 |
| Novo Nordisk | 2 | $24 |
| Exact Sciences | 1 | $24 |
| Boston Scientific | 1 | $22 |
| Biogen | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Abbott | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
How this compares
$1,261 in reported general payments places this provider in the 80th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 67 | $70,722 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 85 | $60,822 |
| EliquisApixaban | 63 | $51,527 |
| JardianceEmpagliflozin | 19 | $23,267 |
| XareltoRivaroxaban | 24 | $21,270 |
| MounjaroTirzepatide | 19 | $19,949 |
| JanuviaSitagliptin Phosphate | 16 | $16,642 |
| FarxigaDapagliflozin Propanediol | 15 | $15,688 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $14,934 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $11,399 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $8,881 |
| TradjentaLinagliptin | 13 | $6,987 |
| MyrbetriqMirabegron | 15 | $6,464 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 44 | $6,288 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 135 | $5,019 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $237 | $81,103127 claims |
| Novo NordiskOzempic | $24 | $70,72267 claims |
| PfizerEliquis | $37 | $51,52763 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $16 | $30,62231 claims |
| Johnson & JohnsonXarelto | $41 | $21,27024 claims |
| Lilly USA, LLCMounjaro | $59 | $19,94919 claims |
| MerckJanuvia | $30 | $16,64216 claims |
| Astellas Pharma US IncMyrbetriq | $24 | $6,46415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Livingston
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.